Mitogen-activated protein kinase (MEK) inhibitors to treat melanoma alone or in combination with other kinase inhibitors

E Faghfuri, S Nikfar, K Niaz, MA Faramarzi… - Expert Opinion on …, 2018 - Taylor & Francis
Introduction: Malignant melanoma (MM) is an aggressive disease with a rapidly rising
incidence due to neoplasm of melanocytes. Molecular targeted therapies have …
被引用次数：26 相关文章

Mitogen-activated protein kinase (MEK) inhibitors to treat melanoma alone or in combination with other kinase inhibitors.

E Faghfuri, S Nikfar, K Niaz, MA Faramarzi… - Expert Opinion on …, 2018 - europepmc.org
Malignant melanoma (MM) is an aggressive disease with a rapidly rising incidence due to
neoplasm of melanocytes. Molecular targeted therapies have demonstrated lower toxicity …
[PDF] academia.edu

[PDF][PDF] Mitogen-activated protein kinase (MEK) inhibitors to treat melanoma alone or in combination with other kinase inhibitors

E Faghfuri, S Nikfar, K Niaz, MA Faramarzi, M Abdollahi - 2018 - academia.edu
Introduction: Malignant melanoma (MM) is an aggressive disease with a rapidly rising
incidence due to neoplasm of melanocytes. Molecular targeted therapies have …

Mitogen-activated protein kinase (MEK) inhibitors to treat melanoma alone or in combination with other kinase inhibitors

E Faghfuri, S Nikfar, K Niaz… - Expert opinion on …, 2018 - pubmed.ncbi.nlm.nih.gov
Malignant melanoma (MM) is an aggressive disease with a rapidly rising incidence due to
neoplasm of melanocytes. Molecular targeted therapies have demonstrated lower toxicity …